Literature DB >> 12719378

A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy.

Ann K Heinzer1, Paul A Watkins, Jyh-Feng Lu, Stephan Kemp, Ann B Moser, Yuan Yuan Li, Stephanie Mihalik, James M Powers, Kirby D Smith.   

Abstract

X-linked adrenoleukodystrophy (X-ALD) is a neurodegenerative and endocrine disorder resulting from mutations in ABCD1 which encodes a peroxisomal membrane protein in the ATP binding cassette superfamily. The biochemical signature of X-ALD is increased levels of saturated very long-chain fatty acids (VLCFA; carbon chains of 22 or more) in tissues and plasma that has been associated with decreased peroxisomal very long-chain acyl-CoA synthetase (VLCS) activity and decreased peroxisomal VLCFA beta-oxidation. It has been hypothesized that ABCD1, which has no demonstrable VLCS activity itself, has an indirect effect on peroxisomal VLCS activity and VLCFA beta-oxidation by transporting fatty acid substrates, VLCS protein or some required co-factor into peroxisomes. Here we report the characterization of a Vlcs knockout mouse that exhibits decreased peroxisomal VLCS activity and VLCFA beta-oxidation but does not accumulate VLCFA. The XALD/Vlcs double knockout mouse has the biochemical abnormalities observed in the individual knockout mice but does not display a more severe X-ALD phenotype. These data lead us to conclude that (1) VLCFA levels are independent of peroxisomal fatty acid beta-oxidation, (2) there is no ABCD1/VLCS interaction and (3) the common severe forms of X-ALD cannot be modeled by decreasing peroxisomal VLCS activity in the XALD mouse.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719378     DOI: 10.1093/hmg/ddg126

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  32 in total

1.  FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase.

Authors:  Alaric Falcon; Holger Doege; Amy Fluitt; Bernice Tsang; Nicki Watson; Mark A Kay; Andreas Stahl
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-06-08       Impact factor: 4.310

Review 2.  Peroxisomal acyl-CoA synthetases.

Authors:  Paul A Watkins; Jessica M Ellis
Journal:  Biochim Biophys Acta       Date:  2012-02-17

Review 3.  Acyl-CoA metabolism and partitioning.

Authors:  Trisha J Grevengoed; Eric L Klett; Rosalind A Coleman
Journal:  Annu Rev Nutr       Date:  2014-04-10       Impact factor: 11.848

Review 4.  Neurodegenerative mutants in Drosophila: a means to identify genes and mechanisms involved in human diseases?

Authors:  Doris Kretzschmar
Journal:  Invert Neurosci       Date:  2005-10-24

5.  Long-chain acyl-CoA synthetases and fatty acid channeling.

Authors:  Douglas G Mashek; Lei O Li; Rosalind A Coleman
Journal:  Future Lipidol       Date:  2007-08

6.  Brain microsomal fatty acid elongation is increased in abcd1-deficient mouse during active myelination phase.

Authors:  Masashi Morita; Misato Kawamichi; Yusuke Shimura; Kosuke Kawaguchi; Shiro Watanabe; Tsuneo Imanaka
Journal:  Metab Brain Dis       Date:  2015-06-25       Impact factor: 3.584

Review 7.  The peroxisomal ABC transporter family.

Authors:  Ronald J A Wanders; Wouter F Visser; Carlo W T van Roermund; Stephan Kemp; Hans R Waterham
Journal:  Pflugers Arch       Date:  2006-10-13       Impact factor: 3.657

Review 8.  PPARalpha: energy combustion, hypolipidemia, inflammation and cancer.

Authors:  Sean R Pyper; Navin Viswakarma; Songtao Yu; Janardan K Reddy
Journal:  Nucl Recept Signal       Date:  2010-04-16

9.  Fatty Acid Transport Proteins: Targeting FATP2 as a Gatekeeper Involved in the Transport of Exogenous Fatty Acids.

Authors:  Paul N Black; Constance Ahowesso; David Montefusco; Nipun Saini; Concetta C DiRusso
Journal:  Medchemcomm       Date:  2016-02-19       Impact factor: 3.597

Review 10.  SLC27 fatty acid transport proteins.

Authors:  Courtney M Anderson; Andreas Stahl
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.